Clinical Trials Directory

Trials / Unknown

UnknownNCT06043908

The Effect of 0.05% CsA Eye Drops on Post-refractive Surgery Dry Eye

The Effect of Topical 0.05% Cyclosporine Eye Drops on Post-refractive Surgery Dry Eye

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined with artificial tears in patients with dry eyes after corneal refractive surgery and to observe the changes in ocular surface characteristics and tear inflammatory cytokines before and after treatment.

Detailed description

The purpose of this study is to observe the effect of 0.05% cyclosporine eyedrops combined with artificial tears in patients with dry eyes after corneal refractive surgery and to observe the changes in ocular surface characteristics and tear inflammatory cytokines before and after treatment. At the same time, this study further observed whether 0.05% cyclosporine eyedrops combined with artificial tear eyedrops were more beneficial to ocular surface repair and tear film homeostasis compared with traditional artificial tears alone.

Conditions

Interventions

TypeNameDescription
DRUGartificial tear eyedropsThe intervention group and control group were treated with artificial tear eyedrops four times a day.
DRUG0.05% cyclosporine eyedropsThe intervention group was treated twice a day.

Timeline

Start date
2022-08-31
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2023-09-21
Last updated
2023-09-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06043908. Inclusion in this directory is not an endorsement.